GOLDMAN SACHS GROUP INC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 114 filers reported holding THERAPEUTICSMD INC in Q3 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$1,087,000
+783.7%
2,860,361
+727.3%
0.00%
Q4 2021$123,000
-66.4%
345,743
-30.0%
0.00%
Q3 2021$366,000
+9.6%
493,845
+75.8%
0.00%
Q2 2021$334,000
-86.6%
280,954
-84.9%
0.00%
-100.0%
Q1 2021$2,490,000
+78.8%
1,858,255
+61.5%
0.00%
Q4 2020$1,393,000
-57.9%
1,150,805
-45.0%
0.00%
-100.0%
Q3 2020$3,305,000
+446.3%
2,091,760
+332.1%
0.00%
Q2 2020$605,000
+19.8%
484,116
+1.6%
0.00%
Q1 2020$505,000
-77.9%
476,358
-49.6%
0.00%
-100.0%
Q4 2019$2,288,000
+92.9%
945,705
+189.6%
0.00%
Q3 2019$1,186,000
-6.5%
326,587
-33.1%
0.00%
Q2 2019$1,268,000
-63.0%
487,882
-30.7%
0.00%
-100.0%
Q1 2019$3,431,000
+81.0%
704,516
+41.6%
0.00%0.0%
Q4 2018$1,896,000
-73.8%
497,609
-54.9%
0.00%
-50.0%
Q3 2018$7,231,000
+31.4%
1,102,242
+25.0%
0.00%
+100.0%
Q2 2018$5,504,000
+138.3%
882,095
+86.0%
0.00%0.0%
Q1 2018$2,310,000
-16.4%
474,208
+3.6%
0.00%0.0%
Q4 2017$2,764,000
+23.3%
457,582
+8.0%
0.00%0.0%
Q3 2017$2,241,000
+5.0%
423,719
+4.6%
0.00%
Q2 2017$2,134,000
-23.0%
404,901
+5.1%
0.00%
-100.0%
Q1 2017$2,772,000
+100.0%
385,102
+60.4%
0.00%
Q4 2016$1,386,000
+42.4%
240,163
+68.1%
0.00%
Q3 2016$973,000
-29.9%
142,863
-12.6%
0.00%
Q2 2016$1,389,000
+8.7%
163,371
-18.2%
0.00%
Q1 2016$1,278,000
-83.5%
199,708
-73.3%
0.00%
-100.0%
Q4 2015$7,764,000
-15.7%
748,725
-52.4%
0.00%
-25.0%
Q3 2015$9,213,000
+923.7%
1,572,046
+1272.6%
0.00%
Q2 2015$900,000
-15.9%
114,534
-35.3%
0.00%
Q1 2015$1,070,000
+540.7%
176,904
+371.3%
0.00%
Q4 2014$167,000
-91.7%
37,533
-91.3%
0.00%
-100.0%
Q3 2014$2,010,000
+1972.2%
433,224
+1869.6%
0.00%
Q2 2014$97,000
-93.3%
21,996
-90.4%
0.00%
Q1 2014$1,447,000
+28.1%
229,314
+5.7%
0.00%
Q4 2013$1,130,000
+448.5%
216,884
+208.7%
0.00%
Q3 2013$206,000
-64.5%
70,250
-63.3%
0.00%
Q2 2013$580,000191,3810.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q3 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders